The BC-CfE’s International Program engages in a number of research and capacity building activities outside of Canada, with a particular focus on low- and middle-income countries with significant HIV epidemics.
Â
These partnerships are undertaken with the principal of trying to build operational research capacity in low- and middle-income countries to evaluate and improve program delivery.
Scroll to Top
CLICK FOR GP-41 DISCONTINUATION NOTICE
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025